Shionogi to Acquire Torii Pharmaceutical

Shionogi to Acquire Torii Pharmaceutical

Isao Teshirogi (center), president and CEO of Shionogi, shakes hands with Nobumasa Kondo (right), president and CEO of Torii Pharmaceutical, and Koji Shimayoshi, executive vice president at Japan Tobacco, in Tokyo on Wednesday.
Isao Teshirogi (center), president and CEO of Shionogi, shakes hands with Nobumasa Kondo (right), president and CEO of Torii Pharmaceutical, and Koji Shimayoshi, executive vice president at Japan Tobacco, in Tokyo on Wednesday.

   Tokyo, May 7 (Jiji Press)--Japanese drugmaker Shionogi & Co. said Wednesday that it will acquire Torii Pharmaceutical Co., a unit of Japan Tobacco Inc., for about 160 billion yen.
   Shionogi will aim to make Torii a fully owned subsidiary by conducting a tender offer and buying JT's stake in the firm. JT will fully withdraw from the pharmaceutical business, transferring all related operations other than Torii to Shionogi as well.

(2025/05/07-21:50)

To read a full story, please click here to find out how to subscribe.

(C)JIJI PRESS LTD., All rights reserved.